In detail, post-translational modification of tight junctions in response to ischemia may activate vascular endothelial growth factor, Rho/ROCK, and cyclic AMP/PKA, causing phosphorylation of tight junction proteins (occludin, claudin-5, and ZO-1) and thus increasing BBB permeability (89). The gene discussed is CLDN5; the disease is ischemia.